Knowledge of HbA1c and LDL‐C treatment goals, subjective level of disease‐related information and information needs in patients with atherosclerotic cardiovascular disease. Issue 2 (30th November 2022)

• Record Type: Journal Article
• Authors: Brockmeyer, Maximilian; Wies, Emilia; Joerges, Jamuna; Sommer, Jana; Borgmann, Sandra Olivia; Chernyak, Nadja; Lin, Yingfeng; Parco, Claudio; Schulze, Volker; Heinen, Yvonne; Kelm, Malte; Icks, Andrea; Perings, Stefan; Wolff, Georg
• Is Part Of: Clinical cardiology. Volume 46:Issue 2(2023)
• Page Start: 223
• Page End: 231
• Publication Date: 2022-11-30
• Subjects: glycated -- hemoglobin (HbA1c) -- information needs -- low‐density lipoprotein cholesterol (LDL cholesterol) -- patient knowledge -- patient information -- treatment goals; Cardiology -- Periodicals; 616.12005
• DOI: 10.1002/clc.23948
• Languages: English
• ISSNs: 0160-9289

Abstract

Abstract: Background/Hypothesis: Risk factor control of diabetes mellitus (DM) and especially dyslipidemia remains unsatisfactory in patients with atherosclerotic cardiovascular disease (ASCVD). We aimed to analyze the knowledge of low‐density lipoprotein cholesterol (LDL‐C) and glycated hemoglobin (HbA1c) treatment goals, subjective level of information, and information needs in very high‐risk patients with ASCVD. Methods: ASCVD patients ( n = 210; 75 ± 9 years; 71.4% male; 89.5% coronary disease) with DM (96.7% type 2) completed a questionnaire assessing knowledge of HbA1c and LDL‐C treatment goals and subjective level of information and information needs on disease‐related topics of DM and ASCVD. Serum LDL‐C and HbA1c were measured. Results: HbA1c goal (<7.0% in 60.6%) was attained more frequently than LDL‐C goal (<70 mg/dl in 39.9%; p < .01). Significantly more participants named the correct goal for HbA1c compared to LDL‐C (52.9% vs. 2.4%; p < .01). Subjective levels of information were higher and information needs were lower for DM than for ASCVD ( p < .01 for all topics). No associations of knowledge of treatment goals and level of information with the attainment of treatment goals for HbA1c and LDL‐C were found. However, in multivariate regression, higher levels of education were associated with knowledge of treatment goals (HbA1c: odds ratio [OR] 1.32, 95% confidence interval [CI] 1.01–1.72, p = .04; LDL‐C: OR 2.32, 95% CI 1.07–5.03; p = .03). Conclusion: In very high‐risk patients with ASCVD, a deficit of knowledge of treatment goals to control dyslipidemia exists when compared to DM, patients felt significantly better informed for topics of DM than for ASCVD and display higher information needs for topics of ASCVD.